Drugs Generic: Neurocrine Biosciences (NASDAQ:NBIX), The Medicines Company (NASDAQ:MDCO), Avanir Pharmaceuticals (NASDAQ:AVNR), Horizon Pharma (NASDAQ:HZNP)

Investors eyeing a purchase of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) stock, but tentative about paying the going market price of $14.27/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the November put at the $11 strike, which has a bid at the time of this writing of $1.65. Neurocrine Biosciences, Inc. (NASDAQ:NBIX) stock performance … Continue reading Drugs Generic: Neurocrine Biosciences (NASDAQ:NBIX), The Medicines Company (NASDAQ:MDCO), Avanir Pharmaceuticals (NASDAQ:AVNR), Horizon Pharma (NASDAQ:HZNP)

Richard Atkins04/0904/09

Small Cap Active Runners: IAMGOLD (NYSE:IAG), Trina Solar (NYSE:TSL), AK Steel Holding Corporation (NYSE:AKS), The Medicines Company (NASDAQ:MDCO)

IAMGOLD Corporation (USA) (NYSE:IAG) announced that a Form 40-F report has been filed with the U.S. Securities and Exchange Commission, consisting of the 2013 annual audited financial statements, management discussion and analysis and the annual information form (‘AIF”). IAMGOLD Corp (USA) (NYSE:IAG) stock performance was -2.27% in last session and finished the day at $3.44. Traded volume was 5.83million shares in the last session and … Continue reading Small Cap Active Runners: IAMGOLD (NYSE:IAG), Trina Solar (NYSE:TSL), AK Steel Holding Corporation (NYSE:AKS), The Medicines Company (NASDAQ:MDCO)

Kristen Barton04/0204/02

Look At 5 Stocks: Huntington Bancshares Incorporated (NASDAQ:HBAN), Mad Catz Interactive Inc. (NYSEMKT:MCZ), SM Energy Company (NYSE:SM), The Medicines (NASDAQ:MDCO), Carnival (NYSE:CUK)

Shares of Huntington Bancshares (NASDAQ:HBAN) saw a large growth in short interest during the month of November. As of November 28th, there was short interest totalling 18,600,104 shares, a growth of 9.6% from the November 14th total of 16,968,635 shares, Analyst Ratings Network.com reports. Huntington Bancshares Incorporated (NASDAQ:HBAN) belongs to Financial sector. Its net profit margin is 30.70% and weekly performance is -3.84%. On last … Continue reading Look At 5 Stocks: Huntington Bancshares Incorporated (NASDAQ:HBAN), Mad Catz Interactive Inc. (NYSEMKT:MCZ), SM Energy Company (NYSE:SM), The Medicines (NASDAQ:MDCO), Carnival (NYSE:CUK)

Adam Keintzel12/16

Why Need to Watch: Dipexium Pharmaceuticals(NASDAQ:DPRX), Yahoo! Inc. (NASDAQ:YHOO), UMH Properties (NYSE:UMH), Consolidated Edison, Inc. (NYSE:ED), The Medicines Company (NASDAQ:MDCO)

On 13 AUG Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX) released its earnings data on Wednesday. The company reported ($0.46) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.37) by $0.09. Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX) belongs to Healthcare sector. Its weekly performance is -2.28%. On last trading day company shares ended up $9.00. Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX) distance from 50-day simple moving average (SMA50) is -5.49%. … Continue reading Why Need to Watch: Dipexium Pharmaceuticals(NASDAQ:DPRX), Yahoo! Inc. (NASDAQ:YHOO), UMH Properties (NYSE:UMH), Consolidated Edison, Inc. (NYSE:ED), The Medicines Company (NASDAQ:MDCO)

Jayne Crisman08/2608/27

Watch List: Neurocrine Biosciences (NASDAQ:NBIX), Karyopharm Therapeutics Inc (NASDAQ:KPTI), Catalyst Pharmaceutical (NASDAQ:CPRX), Supernus Pharmaceuticals Inc (NASDAQ:SUPN), The Medicines Company (NASDAQ:MDCO)

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) announced that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the Jefferies 2014 Global Healthcare Conference in New York City. Neurocrine Biosciences, Inc. (NASDAQ:NBIX) stock performance was 0.22% in last session and finished the day at $13.94. Traded volume was million shares in the last session and the average volume of the stock remained 815.19K … Continue reading Watch List: Neurocrine Biosciences (NASDAQ:NBIX), Karyopharm Therapeutics Inc (NASDAQ:KPTI), Catalyst Pharmaceutical (NASDAQ:CPRX), Supernus Pharmaceuticals Inc (NASDAQ:SUPN), The Medicines Company (NASDAQ:MDCO)

Colin Pettis06/04

Hot Watch List: The Medicines Company (NASDAQ:MDCO), Omeros Corporation (NASDAQ:OMER), Northwest Biotherapeutics (NASDAQ:NWBO), Dehaier Medical Systems (NASDAQ:DHRM), Durata Therapeutics (NASDAQ:DRTX)

The Medicines Company (NASDAQ:MDCO) last issued its quarterly earnings data on Wednesday, April 23rd. The company reported ($0.08) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.07) by $0.01. The company had revenue of $177.20 million for the quarter, compared to the consensus estimate of $175.60 million. During the same quarter last year, the company posted ($0.21) earnings per share. The … Continue reading Hot Watch List: The Medicines Company (NASDAQ:MDCO), Omeros Corporation (NASDAQ:OMER), Northwest Biotherapeutics (NASDAQ:NWBO), Dehaier Medical Systems (NASDAQ:DHRM), Durata Therapeutics (NASDAQ:DRTX)

John Bellich05/27